Position:Full Professor Phone:972-4-8295232 | 972-4-545808004 Fax:972-4-8517797 Email: email@example.com Nathan Karin is a world-leading scientist in molecular and cellular immunology, a member of the Rappaport Inst. for Science and major consultant of two companies (one in Israel and the other in Boston, USA) that have been established based on his 18 patents. His major discovery (Nature, 1992) led to the development of the currently leading drug for Multiple Sclerosis. As an independent scientist he won three international highly ranked research prizes and was elected eight times as the Tension’s excellent lecturer. He also holds a visiting Full Professor appointment at Stanford University School of Medicine.
Gizi Wildbaum, Ph.D. Research AssociatePosition:Lab meager and research director Email: firstname.lastname@example.org Gizi Wildbaum studied her B.Sc. MSc and Ph.D at the biology faculty of the Technion. Here Ph.D studies focused on molecular and genetics aspects in plants biology (1990-1994). One year later she joined, and helped establishing the lab of Nathan Karin. Since then not only has she been the lab manger, but also a leading scientist in immunology, who publishes, as a first author key manuscript in very leading journals (for examples: Wildbaum, Netzer and Karin, JCI 2002; Wildbaum, Nahir and Karin Immunity 2003). Except for directing her independent studies she guides and works very closely with students in the lab, in particularily guiding them along their early steps in the lab.
Yiftah BarsheshetPosition:Senior Ph.D. student Email: email@example.com Yiftah graduated the Biology faculty at the Technion at 2007. Starting an undergraduate project in 2006 In Karin's lab, and thereafter continued to a direct MSc-Ph.D. program. When being asked about his decision Yiftah says: “The love for Immunology research has flourished me and it was natural for me to continue for M.Sc degree and PhD”. His main research focuses on the role of chemokines as potential regulators of T regulatory cells discovering new insights for chemokine receptors patterns on T cells. He is also involved in the establishment of inflammatory bowel disease models understanding immune regulation in a variety of autoimmune diseases side by side with MS models and type1 diabetes.
Elias Hawila: MD\Ph.D. studentEmail: firstname.lastname@example.org Elias received his B.Sc in medicine at the technion in 2010. Elias joined the lab as an MD/PhD research student in 2010. He is currently researching the effect of chemokines and their receptor in cancer using advanced methods of molecular biology, immunology and genetics.
Elias is involved in several other projects in the lab dealing regulating autoimmune diseases such as mice models of MS (multiple sclerosis) and Type 1 Diabetes Mellitus. Elias hopes to pursue a medical career as a doctor as well as integrating research in his daily routine.
Shachar Nehorai, MSc studentEmail: email@example.com Shachar Nehorai graduated the Organism College in 2010 (Haifa University) and then joined the laboratory of Nathan Karin for an MSc thesis. She focuses on exploring regulatory mechanisms in type I diabetes and their clinical relevance.
Sigal Fishman Turjeman, Ph.D. student (in collaboration with Prof. Gidi Gross)Email: firstname.lastname@example.org Sigal obtained her B.Sc. in Biotechnology from Tel-Hai College and her M.Sc. in Human Genetics and Molecular Medicine from Sackler Faculty of Medicine, Tel Aviv University.
Sigal is a Ph.D. student (in full collaboration with Prof. Gidi Gross at Migal). She has started her Ph.D. studies in 2011 and focuses on applying cutting-edge genetic engineering for developing novel immunotherapies for type 1 diabetes.